- Consumer Products
- Latest 13.99
- Currency US$
- Change -0.01
- Percent Change -0.071 %
- Volume 902,468
- Tue Mar 11, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Dec 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Mar 6||$-0.03||May 1||--|
12 months ended Mar 12, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III products in development, including IV APAP, for the treatment of acute pain and fever, and Omigard for the prevention of catheter-related infections. The Company is committed to the fevelopment and commercialization of pharmaceuticals to meet the needs of hospitalized patients and their caregivers.